Crossmark

Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding

Crossref DOI link: https://doi.org/10.1007/s40261-023-01316-0

Published Online: 2023-10-26

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sheikh-Taha, Marwan http://orcid.org/0000-0002-8037-1201
Clark, Holly L.

Crawley, R. Monroe
License Information

Text and Data Mining valid from 2023-10-26

Version of Record valid from 2023-10-26
More Information

Article History

Accepted: 5 October 2023

First Online: 26 October 2023

Declarations

:

: Marwan Sheikh-Taha, Holly L. Clark, and R. Monroe Crawley declare they have no conflicts of interest.

: No sources of funding were used to conduct this study or prepare this manuscript.

: Ethical approval for this study was obtained from Huntsville Hospital’s Institutional Review Committee.

: Not applicable.

: Not applicable.

: Not applicable.

: Conception, design of the work, data collection, interpretation of data, drafting the work, and substantively revising it: MST. Statistical analysis, interpretation of data, drafting the work, and revising it: RMC and HLC.

: Data will be made available on reasonable request

Document is current

Any future updates will be listed below